Research Article

Association of Antibiotic Resistance Traits in Uropathogenic Escherichia coli (UPEC) Isolates

Table 5

Comparative association of antimicrobial resistance in uropathogenic E. coli isolates according to phenotypic and genotypic results.

Antimicrobial agentsCharacteristics of isolateAgreement between phenotypic and genotypic resistance (n = 42)
NPARGsNGP+/G-P-/G+§OR95% CIκ

Ampicillin22CITM51814.220.43–41.450.2160.13
22blaSHV11110412.20–761.790.0120.49
Gentamicin11aac(3)-IV21013.000.17–52.530.4510.08
Streptomycin12aadA131015.80.47–71.070.1690.17
Ciprofloxacin7qnrA53145.333.76–546.250.0020.61
Tetracycline39tet(A)33821.940.16–24.160.6070.07
tet(B)32921.670.13–20.580.6900.05
Chloramphenicol12catA158114.51.42–148.570.0240.36
cmlA862142.25–87.020.0040.48
Trimethoprim-sulphamethaxole20dfrA11561495.31–452.24<0.0010.66
Sulfonamide30sul12651555.73–527.66<0.0010.68
Erythromycin12ere(A)31015.80.47–71.070.1690.17

NP, number of E. coli expressing phenotypic resistance to the indicated antimicrobial agent. NG, number of E. coli carrying the indicated antimicrobial resistance gene. P+/G-, number of phenotypically resistant E. coli (P+) with no resistance gene (G-) for the drug tested. §P-/G+, number of phenotypically susceptible E. coli (P-) with a resistance gene (G+) for the drug tested. Association between AMR phenotypes and ARGs and phenotype-genotype intertest agreement. n, number of E. coli.